Literature DB >> 22505221

Triazole phosphohistidine analogues compatible with the Fmoc-strategy.

Tom E McAllister1, Michael E Webb.   

Abstract

Phosphorylation of histidine is essential for bacterial two-component signalling; its importance to modulation of eukaryotic protein function remains undefined. Until recently, no immunochemical probes of this post-translational modification existed, however triazole phosphonate analogues of this modified amino acid have now been applied to the generation of site-specific antibodies. The protecting group strategy used in the original report is incompatible with standard protocols for Fmoc-solid phase peptide synthesis. In this paper, we report the application of P(III) chemistry to generate the complementary dibenzyl and di-tert-butyl phosphonate esters. These forms of the triazole analogue are fully compatible with standard Fmoc-SPPS and are therefore ideal for wider application by the chemical and biochemical community.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22505221     DOI: 10.1039/c2ob25517k

Source DB:  PubMed          Journal:  Org Biomol Chem        ISSN: 1477-0520            Impact factor:   3.876


  8 in total

1.  Post-translational modifications: Panning for phosphohistidine.

Authors:  Matthew J Piggott; Paul V Attwood
Journal:  Nat Chem Biol       Date:  2013-05-26       Impact factor: 15.040

Review 2.  Advances in development of new tools for the study of phosphohistidine.

Authors:  Mehul V Makwana; Richmond Muimo; Richard Fw Jackson
Journal:  Lab Invest       Date:  2017-12-04       Impact factor: 5.662

3.  Monoclonal 1- and 3-Phosphohistidine Antibodies: New Tools to Study Histidine Phosphorylation.

Authors:  Stephen Rush Fuhs; Jill Meisenhelder; Aaron Aslanian; Li Ma; Anna Zagorska; Magda Stankova; Alan Binnie; Fahad Al-Obeidi; Jacques Mauger; Greg Lemke; John R Yates; Tony Hunter
Journal:  Cell       Date:  2015-07-02       Impact factor: 41.582

Review 4.  pHisphorylation: the emergence of histidine phosphorylation as a reversible regulatory modification.

Authors:  Stephen Rush Fuhs; Tony Hunter
Journal:  Curr Opin Cell Biol       Date:  2017-01-25       Impact factor: 8.382

5.  Structure-based design of nucleoside-derived analogues as sulfotransferase inhibitors.

Authors:  Neil M Kershaw; Dominic P Byrne; Hollie Parsons; Neil G Berry; David G Fernig; Patrick A Eyers; Richard Cosstick
Journal:  RSC Adv       Date:  2019-10-09       Impact factor: 4.036

6.  Synthesis and Use of a Phosphonate Amidine to Generate an Anti-Phosphoarginine-Specific Antibody.

Authors:  Jakob Fuhrmann; Venkataraman Subramanian; Paul R Thompson
Journal:  Angew Chem Int Ed Engl       Date:  2015-10-12       Impact factor: 15.336

Review 7.  Advances in Fmoc solid-phase peptide synthesis.

Authors:  Raymond Behrendt; Peter White; John Offer
Journal:  J Pept Sci       Date:  2016-01       Impact factor: 1.905

8.  Evaluation of the interaction between phosphohistidine analogues and phosphotyrosine binding domains.

Authors:  Tom E McAllister; Katherine A Horner; Michael E Webb
Journal:  Chembiochem       Date:  2014-04-25       Impact factor: 3.164

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.